- Investigaton of adverse effects of carboplatin after experimental local aplication in rabbits bulb2008 | Second Faculty of Medicine
- Hypersensitivity reactions to carboplatin and paclitaxel - our five-years experiences2013 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Vitreous humor versus plazma carboplatin concentration after trancorneal intravitreal and periocular delivery to healthy albino rabbits2009 | Second Faculty of Medicine
- Determination of efficiency and safety of periocular and intravitreal aplication of etoposid and carboplatin in retinoblastoma therapy2010 | Second Faculty of Medicine
- Serum alpha-tocopherol, retinol and neopterin during paclitaxel/caroblatin chemotherapy2007 | Publication without faculty affiliation
- Serum alpha-tocopherol, retinol and neopterin during paclitaxel/caroblatin chemotherapy2007 | Faculty of Medicine in Hradec Králové
- Serum alpha-tocopherol, retinol and neopterin during paclitaxel/caroblatin chemotherapy2007 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. B3271004Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. SLU01Publication without faculty affiliation
- Combined chemotherapy with paclitaxel and carboplatin as second line treatment of small-cell lung carcinoma2005 | Faculty of Medicine in Pilsen
- Chemotherapy with a combination of irinotekan and cis- or carboplatin in first-line treatment of small-cell lung cancer2006 | Faculty of Medicine in Pilsen
- Terapeutické monitorování karboplatiny u dětských pacientů se solidními tumory pomocí bezplamenové absorpční spektrometriePublication without faculty affiliation
- Combined chemotherapy with paclitaxel and carboplatin as second line treatment of small-cell lung carcinoma2005 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Chemotherapy with a combination of irinotekan and cis- or carboplatin in first-line treatment of small-cell lung cancer2006 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- An important progress in the treatment of ovarian cancer after 20 years2012 | Faculty of Medicine in Pilsen
- Our experience with miniICE (ifosfamide, carboplatinum)2001 | First Faculty of Medicine
- Our experience with miniICE (ifosfamide, carboplatinum,2001 | Faculty of Physical Education and Sport
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?2005 | Publication without faculty affiliation
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?2005 | Faculty of Medicine in Hradec Králové
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?2005 | First Faculty of Medicine
- Chemoresistance/chemosensitivity in vitro in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Mezioborová spolupráce při léčbě karcinomu močového měchýře2018 | Second Faculty of Medicine
- Resistance/sensitivity in vitro in ovarian cancer patients2010 | Faculty of Medicine in Hradec Králové
- Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Urinary neopterin, serum retinol, alpha-tocopherol and homocysteine in breast cancer patients during treatment with bevacizumab and chemotherapy2010 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Durvalumab in the treatment of small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Chemoimmunotherapy in the treatment of ES-SCLC2021 | First Faculty of Medicine
- NUT midline pulmonary carcinoma - molecular profiling of three cases and a literature review of the per-spectives for precision oncology2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Cardiotoxicity of anticancer treatment in patients with ovarian cancer2017 | Faculty of Medicine in Hradec Králové
- Immunooncologic therapy of lung cancer. Present and perspectives2020 | Faculty of Medicine in Pilsen